Clinical trial
Optimizing Therapy With Aspirin and Clopidogrel. The BOchum CLopidogrel and Aspirin Plan to Improve Dual Antiplatelet Therapy.
NCT01212302 is registered in ClinicalTrials.gov with Ruhr University of Bochum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing Therapy With Aspirin and Clopidogrel. The BOchum CLopidogrel and Aspirin Plan to Improve Dual Antiplatelet Therapy.
- Lead sponsor
- Ruhr University of Bochum
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2008
- Completion date
- April 30, 2010
- Enrollment
- 500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.